SCHEMBL3666570

SCHEMBL3666570

CCc1nc2c(F)ccc([O])c2c(OC(F)F)c1Cc1ccc(-n2ccc(C3CC3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.53
USP1 O94782 7/20 0.33
MGLL Q99685 2/20 0.31
FAAH O00519 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3666571 0.90 PTGDR2 (0.53) PTGDR2USP1MGLLFAAH
SCHEMBL2571351 0.86 PTGDR2 (0.73) PTGDR2USP1MGLLFAAH
SCHEMBL2575267 0.85 PTGDR2 (0.63) PTGDR2USP1MGLLFAAH
SCHEMBL2577512 0.84 PTGDR2 (0.37) PTGDR2USP1MGLLFAAH
SCHEMBL3667682 0.82 PTGDR2 (0.53) PTGDR2
SCHEMBL534794 0.79 PTGDR2 (0.51) PTGDR2
SCHEMBL2673148 0.78 PTGDR2 (0.64) PTGDR2USP1MGLLFAAH
SCHEMBL3664108 0.77 PTGDR2 (0.42) PTGDR2
SCHEMBL534920 0.77 PTGDR2 (0.49) PTGDR2
SCHEMBL534080 0.77 PTGDR2 (0.51) PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139881-A1 QUINOLINES AND THEIR THERAPEUTIC USE Argenta Oral Therapeutics Limited (GB) 2010-01-06 EP disclosed
WO-2008122784-A1 QUINOLINES AND THEIR THERAPEUTIC USE ARGENTA DISCOVERY LIMITED (GB) 2008-10-16 WO disclosed